NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma.
| Publicado en: | BMC Pulmonary Medicine Vol. 24; pp. 1 - 17 |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
5/19/2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |